Journal of medicinal and pharmaceutical chemistry 2011-04-28

Organometallic half-sandwich iridium anticancer complexes.

Zhe Liu, Abraha Habtemariam, Ana M Pizarro, Sally A Fletcher, Anna Kisova, Oldrich Vrana, Luca Salassa, Pieter C A Bruijnincx, Guy J Clarkson, Viktor Brabec, Peter J Sadler

Index: J. Med. Chem. 54 , 3011-3026, (2011)

Full Text: HTML

Abstract

The low-spin 5d(6) Ir(III) organometallic half-sandwich complexes [(η(5)-Cp(x))Ir(XY)Cl](0/+), Cp(x) = Cp*, tetramethyl(phenyl)cyclopentadienyl (Cp(xph)), or tetramethyl(biphenyl)cyclopentadienyl (Cp(xbiph)), XY = 1,10-phenanthroline (4-6), 2,2'-bipyridine (7-9), ethylenediamine (10 and 11), or picolinate (12-14), hydrolyze rapidly. Complexes with N,N-chelating ligands readily form adducts with 9-ethylguanine but not 9-ethyladenine; picolinate complexes bind to both purines. Cytotoxic potency toward A2780 human ovarian cancer cells increases with phenyl substitution on Cp*: Cp(xbiph) > Cp(xph) > Cp*; Cp(xbiph) complexes 6 and 9 have submicromolar activity. Guanine residues are preferential binding sites for 4-6 on plasmid DNA. Hydrophobicity (log P), cell and nucleus accumulation of Ir correlate with cytotoxicity, 6 > 5 > 4; they distribute similarly within cells. The ability to displace DNA intercalator ethidium bromide from DNA correlates with cytotoxicity and viscosity of Ir-DNA adducts. The hydrophobicity and intercalative ability of Cp(xph) and Cp(xbiph) make a major contribution to the anticancer potency of their Ir(III) complexes.

Related Compounds

  • 9-ethylguanine

Related Articles:

Protein ruthenation and DNA alkylation: chlorambucil-functionalized RAPTA complexes and their anticancer activity.

2015-02-28

[Dalton Trans. 44(8) , 3614-23, (2015)]

Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicity.

2013-04-25

[Chem. Commun. (Camb.) 49(32) , 3348-50, (2013)]

Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.

2009-12-10

[J. Med. Chem. 52(23) , 7753-64, (2009)]

Unprecedented head-to-head conformers of d(GpG) bound to the antitumor active compound tetrakis (mu-carboxylato)dirhodium(II,II).

2003-09-03

[J. Am. Chem. Soc. 125(35) , 10703-13, (2003)]

Novel binding interactions of the DNA fragment d(pGpG) cross-linked by the antitumor active compound tetrakis(mu-carboxylato)dirhodium(II,II).

2003-09-03

[J. Am. Chem. Soc. 125(35) , 10714-24, (2003)]

More Articles...